Menu Search
Equities

Bio Vitos Pharma AB

BIOVIT:STO

Bio Vitos Pharma AB

Actions
Health CareMedical Equipment and Services
  • Price (SEK)0.126
  • Today's Change-0.003 / -2.33%
  • Shares traded258.76k
  • 1 Year change-31.89%
  • Beta1.6723
Data delayed at least 15 minutes, as of Sep 20 2024 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in SEKView more

In 2023, Bio Vitos Pharma AB did not generate a significant amount of cash. Cash Flow from Financing totalled 4.00m or 133.53% of revenues. In addition the company used 3.97m for operations while cash used for investing totalled 145.00k.
Cash flow per share-0.0263
Price/Cash flow per share--
Book value per share0.0905
Tangible book value per share0.0096
More ▼

Balance sheet in SEKView more

Bio Vitos Pharma AB has little financial risk as the capital structure does not rely on leverage.
Current ratio8.50
Quick ratio5.84
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.